Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression-Reference-Cited by-同舟云学术

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression

Published:2019-07-26 Issue:1 Volume:7 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

De Suman,Whiten Daniel R.,Ruggeri Francesco S.,Hughes Craig,Rodrigues Margarida,Sideris Dimitrios I.,Taylor Christopher G.,Aprile Francesco A.,Muyldermans Serge,Knowles Tuomas P. J.,Vendruscolo Michele,Bryant Clare,Blennow Kaj,Skoog Ingmar,Kern Silke,Zetterberg Henrik,Klenerman David^ORCID

Funder

European Research Council

Vetenskapsrådet

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-019-0777-4.pdf

Reference43 articles.

1. Aprile FA, Sormanni P, Perni M, Arosio P, Linse S, Knowles TPJ et al (2017) Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method. Sci Adv 3:e1700488 Available from: https://advances.sciencemag.org/content/3/6/e1700488

2. Benilova I, Karran E, De Strooper B (2012) The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci 15:349–357. https://doi.org/10.1038/nn.3028